This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006 Dec;11(4):74-81.

Detection and significance of minority quasispecies of drug-resistant HIV-1

Karin J Metzner¹

Affiliations

PMID: 17578210

Review

Detection and significance of minority quasispecies of drug-resistant HIV-1

Karin J Metzner. J HIV Ther. 2006 Dec.

. 2006 Dec;11(4):74-81.

Author

Karin J Metzner¹

Affiliation

¹ Institute of Clinical and Molecular Virology, University of Erlangen-Nuremberg, Schlossgarten, Erlangen, Germany. karin.metzner@viro.med.uni-erlangen.de

PMID: 17578210

No abstract available

PubMed Disclaimer

Similar articles

Clinical utility of resistance testing.
Stebbing J, Gazzard BG. Stebbing J, et al. J HIV Ther. 2002 Nov;7(4):75-9. J HIV Ther. 2002. PMID: 12733604 No abstract available.
Interpretation of resistance assay results.
Miller V. Miller V. Antivir Ther. 2001;6 Suppl 2:1-9. Antivir Ther. 2001. PMID: 11678473 No abstract available.
Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution.
Johnson JA, Geretti AM. Johnson JA, et al. J Antimicrob Chemother. 2010 Jul;65(7):1322-6. doi: 10.1093/jac/dkq139. Epub 2010 May 13. J Antimicrob Chemother. 2010. PMID: 20466851 Review.
Antiretroviral resistance.
Geretti AM. Geretti AM. J HIV Ther. 2006 Dec;11(4):72-3. J HIV Ther. 2006. PMID: 17578209 No abstract available.
Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
Vercauteren J, Vandamme AM. Vercauteren J, et al. Antiviral Res. 2006 Sep;71(2-3):335-42. doi: 10.1016/j.antiviral.2006.05.003. Epub 2006 May 30. Antiviral Res. 2006. PMID: 16782210 Review.

See all similar articles

Cited by

Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.
Mbunkah HA, Bertagnolio S, Hamers RL, Hunt G, Inzaule S, Rinke De Wit TF, Paredes R, Parkin NT, Jordan MR, Metzner KJ; WHO HIVResNet Working Group. Mbunkah HA, et al. J Infect Dis. 2020 Apr 27;221(10):1584-1597. doi: 10.1093/infdis/jiz650. J Infect Dis. 2020. PMID: 31809534 Free PMC article.
Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection.
Stekler JD, Ellis GM, Carlsson J, Eilers B, Holte S, Maenza J, Stevens CE, Collier AC, Frenkel LM. Stekler JD, et al. PLoS One. 2011;6(12):e28952. doi: 10.1371/journal.pone.0028952. Epub 2011 Dec 16. PLoS One. 2011. PMID: 22194957 Free PMC article.
Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection.
Metzner KJ, Leemann C, Di Giallonardo F, Grube C, Scherrer AU, Braun D, Kuster H, Weber R, Guenthard HF. Metzner KJ, et al. PLoS One. 2011;6(7):e21734. doi: 10.1371/journal.pone.0021734. Epub 2011 Jul 6. PLoS One. 2011. PMID: 21754996 Free PMC article. Clinical Trial.
Association of preexisting drug-resistance mutations and treatment failure in hepatitis B patients.
Ma J, Zhang Y, Chen X, Jin Y, Chen D, Wu Y, Cui J, Wang H, Liu J, Li N, Gao F. Ma J, et al. PLoS One. 2013 Jul 30;8(7):e67606. doi: 10.1371/journal.pone.0067606. Print 2013. PLoS One. 2013. PMID: 23935839 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information